Dasatinib
NDC 66993-238, dasatinib, tablet, from Prasco Laboratories.
- Product NDC
- 66993-238
- Status
- Listed
- Labeler
- Prasco Laboratories
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021986
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66993-238 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB140 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66993-238-30 | 66993023830 | 1 BOTTLE in 1 CARTON (66993-238-30) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1931e73f-918c-4d69-9543-de9643513d05
Use it
Look up 66993-238 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66993-238 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66993-238. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.